Our simple recombinant protein expression system increases yields and allows for cheap production of proteins and protein complexes, including antibodies.
We have developed plasmids to produce N-terminal acetylation machinery in E. coli, allowing recombinant proteins to be produced and acetylated within bacterial systems.